Shoei Pharmaceutical Co., Ltd. <3537> announced on the 13th that it will distribute surplus funds (dividends) based on March 31, 2024.

The company's basic policy is to continue to implement stable dividends to shareholders while striving for improved performance and securing internal reserves necessary for future business development from a long-term perspective. The target dividend payout ratio is 25% or more of net income attributable to the parent company's shareholders based on the dividend per share in past years.

For the year-ending dividend for March 2024, it was expected to be 36 yen per share, but based on the basic policy and comprehensive consideration of the current performance, it has been increased by 2 yen from the latest estimate and revised to 38 yen per share. As a result, the annual dividend per share for March 2024 will be 38 yen, with a dividend payout ratio of 26.3%. This matter is scheduled to be submitted to the 64th Regular Shareholders' Meeting to be held on June 25, 2024.